A biomarker is defined as "a trait that is objectively measured and analysed as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention" by the National Institutes of Health Biomarkers Definitions Working Group in 1998. Biomarkers are now so widely used in scientific and clinical research, as well as clinical practice, that their inclusion as primary endpoints in clinical trials is nearly unquestioned. A large subgroup of medical indicators – that is, objective signals of medical state viewed from outside the patient – that can be assessed accurately and reproducibly is referred to as a "biomarker," a portmanteau of "biological marker." Medical signals are distinct from medical symptoms, which are limited to the signs of health or illness that patients perceive. Biomarkers are objective, quantifiable aspects of biological processes by definition. They may or may not correlate with a patient's experience and sense of well-being, and it's possible to conceive measurable biological traits that don't correspond to a patient's clinical state, or whose fluctuations are undetectable and have no impact on health. It's also easy to conceive observable biological features with such wide variation among populations that they're all but useless as accurate predictors of disease or absence.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States